Osimertinib plus anlotinib for advanced NSCLC with acquired EGFR T790M mutation: results from a multicenter phase II study with ctDNA analysis.

Saved in:
Bibliographic Details
Title: Osimertinib plus anlotinib for advanced NSCLC with acquired EGFR T790M mutation: results from a multicenter phase II study with ctDNA analysis.
Authors: Wang, Xinyue1 (AUTHOR), Li, Zhaona2 (AUTHOR), Wang, Liuchun1 (AUTHOR), Liang, Yan1 (AUTHOR), Huang, Chun1 (AUTHOR), Chen, Peng1 (AUTHOR), Huang, Dingzhi1 (AUTHOR), Song, Xia3 (AUTHOR), Ding, Cuimin4 (AUTHOR) wjwdcm@sina.com, Wang, Changli5 (AUTHOR) wangchangli@tjmuch.com, Jiang, Richeng1,6 (AUTHOR) jiangricheng@tjmuch.com
Source: BMC Medicine. 4/15/2025, Vol. 23 Issue 1, p1-11. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 184488825
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Osimertinib plus anlotinib for advanced NSCLC with acquired EGFR T790M mutation: results from a multicenter phase II study with ctDNA analysis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Wang%2C+Xinyue%22">Wang, Xinyue</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+Zhaona%22">Li, Zhaona</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Liuchun%22">Wang, Liuchun</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liang%2C+Yan%22">Liang, Yan</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Huang%2C+Chun%22">Huang, Chun</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chen%2C+Peng%22">Chen, Peng</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Huang%2C+Dingzhi%22">Huang, Dingzhi</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Song%2C+Xia%22">Song, Xia</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ding%2C+Cuimin%22">Ding, Cuimin</searchLink><relatesTo>4</relatesTo> (AUTHOR)<i> wjwdcm@sina.com</i><br /><searchLink fieldCode="AR" term="%22Wang%2C+Changli%22">Wang, Changli</searchLink><relatesTo>5</relatesTo> (AUTHOR)<i> wangchangli@tjmuch.com</i><br /><searchLink fieldCode="AR" term="%22Jiang%2C+Richeng%22">Jiang, Richeng</searchLink><relatesTo>1,6</relatesTo> (AUTHOR)<i> jiangricheng@tjmuch.com</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22BMC+Medicine%22">BMC Medicine</searchLink>. 4/15/2025, Vol. 23 Issue 1, p1-11. 11p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=184488825
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s12916-025-04044-8
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 11
        StartPage: 1
    Titles:
      – TitleFull: Osimertinib plus anlotinib for advanced NSCLC with acquired EGFR T790M mutation: results from a multicenter phase II study with ctDNA analysis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wang, Xinyue
      – PersonEntity:
          Name:
            NameFull: Li, Zhaona
      – PersonEntity:
          Name:
            NameFull: Wang, Liuchun
      – PersonEntity:
          Name:
            NameFull: Liang, Yan
      – PersonEntity:
          Name:
            NameFull: Huang, Chun
      – PersonEntity:
          Name:
            NameFull: Chen, Peng
      – PersonEntity:
          Name:
            NameFull: Huang, Dingzhi
      – PersonEntity:
          Name:
            NameFull: Song, Xia
      – PersonEntity:
          Name:
            NameFull: Ding, Cuimin
      – PersonEntity:
          Name:
            NameFull: Wang, Changli
      – PersonEntity:
          Name:
            NameFull: Jiang, Richeng
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 04
              Text: 4/15/2025
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 17417015
          Numbering:
            – Type: volume
              Value: 23
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: BMC Medicine
              Type: main
ResultId 1